MedMira specializes in rapid diagnostic testing technologies, primarily utilizing their patented Rapid Vertical Flow (RVF) Technology™. This innovative platform is designed to deliver fast and accurate results for a variety of infectious diseases, including HIV, Hepatitis B and C, and syphilis. The RVF Technology enables simultaneous testing for multiple biomarkers using a single cartridge, which simplifies the testing process and reduces the need for complex procedures or specialized training. The tests can be performed with whole blood, serum, or plasma specimens, and they provide instant results, significantly improving patient care by allowing immediate treatment decisions.

In addition to their rapid testing solutions, MedMira offers the Miriad RVF Toolkit, which supports researchers and developers in creating new diagnostic tests. This toolkit facilitates the transition of existing test concepts to the RVF platform, streamlining the development process and lowering barriers to market entry. MedMira's commitment to quality is reflected in their compliance with stringent regulatory standards, ensuring that their products meet the highest safety and efficacy requirements. Through collaborations and licensing agreements, MedMira aims to expand the reach of their RVF Technology, contributing to global health improvements.

Canada

MedMira is transforming rapid testing with our patented Rapid Vertical Flow Technology™, offering speed, accuracy and multiplexing. This technology enables targets of interest in a wide variety of sample types to be captured and visualized on a unique membrane. Rapid Vertical Flow Technology is a highly scalable solution that can be used in the development and commercialization of rapid testing applications across a broad range of life sciences and biotech sectors. It’s rapid testing reinvented.

MedMira

Company Details